Published in Kidney Int on September 01, 1991
Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol (2005) 2.08
Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. J Clin Invest (1998) 1.88
Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol (2008) 1.72
Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med (2009) 1.49
The renaissance of corticotropin therapy in proteinuric nephropathies. Nat Rev Nephrol (2011) 1.28
T regulatory cell function in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol (2009) 1.25
Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2009) 1.21
Rituximab therapy in nephrotic syndrome: implications for patients' management. Nat Rev Nephrol (2013) 1.18
Idiopathic nephrotic syndrome and atopy: is there a common link? Am J Kidney Dis (2009) 1.13
Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol (1995) 1.09
Role of T cells and dendritic cells in glomerular immunopathology. Semin Immunopathol (2007) 1.08
A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol (2006) 1.03
The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review. J Transplant (2011) 0.97
Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome. Clin Exp Immunol (2010) 0.97
Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS. Clin J Am Soc Nephrol (2014) 0.96
Leveraging melanocortin pathways to treat glomerular diseases. Adv Chronic Kidney Dis (2014) 0.95
Proteinuria: is it all in the foot? J Clin Invest (2007) 0.94
Regulatory T cells and minimal change nephropathy: in the midst of a complex network. Clin Exp Immunol (2015) 0.93
Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol (2011) 0.91
Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol (1999) 0.88
Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes. Pediatr Nephrol (2013) 0.88
Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol (2003) 0.87
New insights into mechanisms of immune glomerular injury. West J Med (1994) 0.87
Characterisation of renal immune cell infiltrates in children with nephrotic syndrome. Pediatr Nephrol (2010) 0.86
The spectrum of kidney involvement in lymphoma: a case report and review of the literature. Am J Kidney Dis (2010) 0.86
LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity. PLoS One (2014) 0.85
Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome. Pediatr Nephrol (2009) 0.83
Altered expression of glomerular heat shock protein 27 in experimental nephrotic syndrome. J Clin Invest (1996) 0.83
DNA methylation changes between relapse and remission of minimal change nephrotic syndrome. Pediatr Nephrol (2012) 0.82
Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol (2007) 0.82
Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome. Clin Exp Immunol (2011) 0.82
Cure of relapsing nephrosis by an allogeneic marrow graft for chronic myelogenous leukemia. Pediatr Nephrol (2013) 0.81
Role of basophils in the pathogenesis of minimal change nephrotic syndrome: A literature review. Exp Ther Med (2014) 0.80
Monoclonal antibodies for podocytopathies: rationale and clinical responses. Nat Rev Nephrol (2009) 0.79
Expression of immunoglobulin E-dependent histamine-releasing factor in idiopathic nephrotic syndrome of childhood. Clin Exp Immunol (2005) 0.78
Complete remission of post-transplant FSGS recurrence by long-term plasmapheresis. Pediatr Nephrol (2005) 0.78
Immunopathogenesis of idiopathic nephrotic syndrome with relapse. Semin Immunopathol (2014) 0.78
Low birth weight, but not postnatal weight gain, aggravates the course of nephrotic syndrome. Pediatr Nephrol (2007) 0.78
Advances in apheresis therapy for glomerular diseases. Clin Exp Nephrol (2007) 0.78
Minimal change disease and idiopathic FSGS: manifestations of the same disease. Nat Rev Nephrol (2016) 0.77
MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy. Sci Rep (2016) 0.76
Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient. Nat Clin Pract Nephrol (2006) 0.76
Minimal Change Disease. Clin J Am Soc Nephrol (2016) 0.75
A Unique Cause of Proteinuria in Pregnancy: Class II Lupus Nephritis with Concomitant Minimal Change Disease. Case Rep Nephrol Dial (2016) 0.75
Minimal-Change Disease Secondary to Borrelia burgdorferi Infection. Case Rep Nephrol (2012) 0.75
Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome? PLoS One (2016) 0.75
Markers of disease and steroid responsiveness in paediatric idiopathic nephrotic syndrome: Whole-transcriptome sequencing of peripheral blood mononuclear cells. J Int Med Res (2017) 0.75
Changes in DNA methylation in naïve T helper cells regulate the pathophysiological state in minimal-change nephrotic syndrome. BMC Res Notes (2017) 0.75
Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol (1996) 72.84
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature (1999) 8.70
A highly sensitive method to assay FK-506 levels in plasma. Transplant Proc (1987) 8.45
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med (1992) 8.27
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol (1991) 6.30
Green revolution: a mutant gibberellin-synthesis gene in rice. Nature (2002) 5.84
Identification of CRE1 as a cytokinin receptor from Arabidopsis. Nature (2001) 4.77
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci U S A (1987) 4.72
A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol (2000) 4.25
Regulation of drought tolerance by gene manipulation of 9-cis-epoxycarotenoid dioxygenase, a key enzyme in abscisic acid biosynthesis in Arabidopsis. Plant J (2001) 3.92
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology (2000) 3.42
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest (1999) 3.18
Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A (1995) 3.06
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int (2006) 3.00
Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J (1994) 2.95
Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int (2001) 2.90
Successful treatment of Behçet disease with pentoxifylline. Ann Intern Med (1996) 2.81
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med (1992) 2.71
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology (1998) 2.67
Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc (1981) 2.62
Molecular clock of silent substitution: at least six-fold preponderance of silent changes in mitochondrial genes over those in nuclear genes. J Mol Evol (1982) 2.58
Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene (1984) 2.56
Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol (2001) 2.52
Rice dwarf mutant d1, which is defective in the alpha subunit of the heterotrimeric G protein, affects gibberellin signal transduction. Proc Natl Acad Sci U S A (2000) 2.51
Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis (1997) 2.40
The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem (1989) 2.37
Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation. J Exp Med (1986) 2.33
1/f fluctuation of heartbeat period. IEEE Trans Biomed Eng (1982) 2.32
Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J Immunol (1987) 2.24
Antisense suppression of proline degradation improves tolerance to freezing and salinity in Arabidopsis thaliana. FEBS Lett (1999) 2.24
Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med (1986) 2.23
Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol (1998) 2.21
Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy. AJR Am J Roentgenol (2000) 2.20
Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol Cell Biol (2001) 2.18
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. Circulation (2000) 2.18
Overexpression of the robA gene increases organic solvent tolerance and multiple antibiotic and heavy metal ion resistance in Escherichia coli. Appl Environ Microbiol (1995) 2.18
Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med (1991) 2.17
Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res (2001) 2.14
Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med (1985) 2.11
Identification of a new variable sequence in the P1 cytadhesin gene of Mycoplasma pneumoniae: evidence for the generation of antigenic variation by DNA recombination between repetitive sequences. Infect Immun (1999) 2.11
Cloning and functional analysis of two gibberellin 3 beta -hydroxylase genes that are differently expressed during the growth of rice. Proc Natl Acad Sci U S A (2001) 2.09
An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol (1991) 2.04
PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet (1998) 2.02
A structurally abnormal insulin causing human diabetes. Nature (1979) 1.99
Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli. Appl Environ Microbiol (1997) 1.98
Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol (1998) 1.97
Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology (1994) 1.96
Biological functions of proline in morphogenesis and osmotolerance revealed in antisense transgenic Arabidopsis thaliana. Plant J (1999) 1.95
Can we stop national immunisation days before global eradication of poliomyelitis? Lancet (1999) 1.92
p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene (1999) 1.90
Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol (1992) 1.88
Expression of a gibberellin 2-oxidase gene around the shoot apex is related to phase transition in rice. Plant Physiol (2001) 1.86
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology (1992) 1.85
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation (1992) 1.83
Kawasaki disease in families. Pediatrics (1989) 1.83
A phylogenetically conserved sequence within viral 3' untranslated RNA pseudoknots regulates translation. Mol Cell Biol (1993) 1.82
Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med (1996) 1.81
Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology (1993) 1.81
The dwarf-1 (dt) Mutant of Zea mays blocks three steps in the gibberellin-biosynthetic pathway. Proc Natl Acad Sci U S A (1996) 1.80
Impaired motor facilitation during action observation in individuals with autism spectrum disorder. Curr Biol (2005) 1.80
Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res (2001) 1.79
Recurrent meningitis and Mondini dysplasia. Arch Otolaryngol Head Neck Surg (1990) 1.77
Molecular assembly of the influenza virus RNA polymerase: determination of the subunit-subunit contact sites. J Gen Virol (1996) 1.77
Phosphatidylethanol formation via transphosphatidylation by rat brain synaptosomal phospholipase D. J Neurochem (1987) 1.77
Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2008) 1.76
Two distinct types of repression domain in engrailed: one interacts with the groucho corepressor and is preferentially active on integrated target genes. Mol Cell Biol (1998) 1.76
A stress-inducible gene for 9-cis-epoxycarotenoid dioxygenase involved in abscisic acid biosynthesis under water stress in drought-tolerant cowpea. Plant Physiol (2000) 1.75
The 5' upstream region of mPer1 gene contains two promoters and is responsible for circadian oscillation. Curr Biol (2000) 1.74
Isolation and structure of the bacterial sex pheromone, cAD1, that induces plasmid transfer in Streptococcus faecalis. FEBS Lett (1984) 1.73
Establishment of pure NOTES procedure using a conventional flexible endoscope: review of six cases of gastric gastrointestinal stromal tumors. Endoscopy (2011) 1.73
Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature (1996) 1.73
Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis. Clin Exp Allergy (1990) 1.71
Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Lab Invest (1998) 1.68
Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon. Am J Surg Pathol (1997) 1.67
Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol (1996) 1.67
Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br J Anaesth (2006) 1.64
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial. Br J Cancer (2003) 1.63
Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography. J Pharm Biomed Anal (1999) 1.62
Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis (1981) 1.62
Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med (1998) 1.61
A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. J Biol Regul Homeost Agents (2008) 1.61
Amino acid sequence of heat-stable enterotoxin produced by Vibrio cholerae non-01. FEBS Lett (1985) 1.60
Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood (1997) 1.60
International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome. Br J Haematol (2001) 1.59
Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab (1988) 1.59
Fatty acid abnormality in adrenoleukodystrophy. J Neurochem (1976) 1.58
Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci. J Biol Chem (1999) 1.58
Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site. Proc Natl Acad Sci U S A (1985) 1.57